Company intelligence / Profile preview
Napp Pharmaceuticals
Cambridge, England, United Kingdomnapp.co.uk ↗
- Ownership
- Private
- Employees
- ~486
- Development stage
- Commercial
01
Overview
Napp Pharmaceuticals has an established commercial presence in the UK, offering products in pain management (including branded forms of oxycodone) and a broad range of therapies for chronic conditions such as diabetes, respiratory disease, cancer, arthritis, and gastrointestinal disorders[1][3][5]. The company introduced a prominent delivery technology (Continus®) for sustained drug release and has focused on supporting patient needs and the NHS with innovative medicines[1][4][5].
- Therapeutic areas
- OncologyPulmonologyRheumatologyNeurologyEndocrinologyGastroenterology
- Modalities
- Small moleculeBiologic
- Industry
- Pharma
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Napp Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Napp Pharmaceuticals.